Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Kohlmeier M, Dong OM. Exercise-induced muscle damage in healthy men with low choline intake. Poster presented at the 2016 Experimental Biology Conference; April 3, 2016. San Diego, CA. [abstract] J Exp Biol. 2016 Apr; 30(S1).
Dalley C, Basarir H, Wright JG, Fernando M, Pearson D, Ward SE, Thokula P, Krishnankutty A, Wilson G, Dalton A, Talley P, Barnett D, Hughes D, Porter NR, Reilly JT, Snowden JA. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model. J Clin Pathol. 2015 Apr;68(4):292-300. doi: 10.1136/jclinpath-2014-202624
Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Anal Chem. 1992;64(14):1541.